Context Therapeutics CNTX SEC Filings

NASDAQ CNTX
$0.17 +0.00 (+0.00%)
At close: Nov 19, 2026 · 4:00 PM EST
EDGAR Disclosures

Latest SEC Filings

Latest filing 8-K ·
Source SEC EDGAR

Context Therapeutics (CNTX) has filed 309 documents with the SEC since March 2021, all on EDGAR under CIK 1842952. In the last 12 months it filed 43, including 1 annual report (10-K), 3 quarterly reports (10-Q), 12 current reports (8-K) and 10 insider filings (Form 4). The latest, a current report (8-K), was filed on Nov 10, 2026.

Form Type
# Form Type Description Accession Filed Filing Index
18-KCurrent report: Reg FD disclosure, other events0001628280-26-072768Nov 10, 2026 11:23 AM ET
210-QQuarterly report · quarter ended Sep 30, 20260001628280-26-072730Nov 10, 2026 11:12 AM ET
3SCHEDULE 13G5%+ passive stake0001687078-26-000020Aug 14, 2026 4:03 PM ET
4SCHEDULE 13G5%+ passive stake0001140361-26-032506Aug 12, 2026 4:30 PM ET
58-KCurrent report: Reg FD disclosure0001628280-26-053378Aug 5, 2026 4:16 PM ET
610-QQuarterly report · quarter ended Jun 30, 20260001628280-26-053347Aug 5, 2026 4:09 PM ET
78-KCurrent report: listing standard notice0001628280-26-051399Jul 31, 2026 4:08 PM ET
8SCHEDULE 13G5%+ passive stake0001214659-26-009404Jul 31, 2026 4:01 PM ET
9SCHEDULE 13G5%+ passive stake0002012383-26-002242Jul 27, 2026 4:25 PM ET
104Insider transaction0001628280-26-045789Jun 26, 2026 4:23 PM ET
114Insider transaction0001628280-26-045784Jun 26, 2026 4:21 PM ET
124Insider transaction0001628280-26-045780Jun 26, 2026 4:21 PM ET
134Insider transaction0001628280-26-045778Jun 26, 2026 4:20 PM ET
144Insider transaction0001628280-26-045775Jun 26, 2026 4:19 PM ET
154Insider transaction0001628280-26-045762Jun 26, 2026 4:13 PM ET
168-KCurrent report: charter or bylaw change, shareholder vote results0001628280-26-045744Jun 26, 2026 4:07 PM ET
178-KCurrent report: Reg FD disclosure, other events0001628280-26-043042Jun 15, 2026 9:18 AM ET
188-KCurrent report: material agreement, Reg FD disclosure0001628280-26-035793May 18, 2026 6:47 AM ET
19SCHEDULE 13G5%+ passive stake0001172661-26-002036May 15, 2026 8:55 AM ET
20SCHEDULE 13G5%+ passive stake0001140361-26-021316May 14, 2026 4:20 PM ET
21SCHEDULE 13G5%+ passive stake0001214659-26-006201May 14, 2026 4:01 PM ET
22SCHEDULE 13G5%+ passive stake0000919574-26-002869May 12, 2026 3:07 PM ET
23SCHEDULE 13G5%+ passive stake0001213900-26-053988May 8, 2026 5:00 PM ET
2410-QQuarterly report · quarter ended Mar 31, 20260001628280-26-031267May 6, 2026 4:10 PM ET
258-KCurrent report: other events0001628280-26-029323May 1, 2026 4:07 PM ET
26ARSAnnual report to shareholders0001628280-26-027962Apr 28, 2026 4:29 PM ET
27DEFA14AAdditional proxy materials0001628280-26-027942Apr 28, 2026 4:15 PM ET
28DEF 14AProxy statement0001628280-26-027928Apr 28, 2026 4:12 PM ET
29PRE 14APreliminary proxy statement0001628280-26-025776Apr 17, 2026 4:29 PM ET
308-KCurrent report: Reg FD disclosure, other events0001628280-26-022931Apr 2, 2026 7:41 AM ET
31S-8Employee stock plan registration0001628280-26-020575Mar 23, 2026 5:08 PM ET
328-KCurrent report: Reg FD disclosure, other events0001628280-26-020517Mar 23, 2026 4:22 PM ET
3310-KAnnual report · fiscal year ended Dec 31, 20250001628280-26-020498Mar 23, 2026 4:09 PM ET
348-KCurrent report: charter or bylaw change, other events0001628280-26-017691Mar 13, 2026 4:09 PM ET
358-KCurrent report: other events0001628280-26-012813Feb 27, 2026 4:11 PM ET
364Insider transaction0001628280-26-010660Feb 23, 2026 4:24 PM ET
374Insider transaction0001628280-26-010642Feb 23, 2026 4:21 PM ET
384Insider transaction0001628280-26-010637Feb 23, 2026 4:18 PM ET
394Insider transaction0001628280-26-010616Feb 23, 2026 4:13 PM ET
40SCHEDULE 13G5%+ passive stake0001172661-26-001118Feb 17, 2026 4:17 PM ET
41SCHEDULE 13G5%+ passive stake0001687078-26-000005Feb 17, 2026 4:09 PM ET
42SCHEDULE 13G5%+ passive stake0001213900-26-011516Feb 3, 2026 4:41 PM ET
438-KCurrent report: Reg FD disclosure0001628280-26-001275Jan 8, 2026 7:43 AM ET
44SCHEDULE 13G5%+ passive stake0000919574-25-007016Nov 14, 2025 4:27 PM ET
45SCHEDULE 13G5%+ passive stake0001814554-25-000171Nov 14, 2025 1:16 PM ET
468-KCurrent report: Reg FD disclosure, other events0001628280-25-049604Nov 5, 2025 4:21 PM ET
4710-QQuarterly report · quarter ended Sep 30, 20250001628280-25-049533Nov 5, 2025 4:08 PM ET
488-KCurrent report: material agreement, other events0001628280-25-046258Oct 24, 2025 4:02 PM ET
49424B5Prospectus supplement0001628280-25-046256Oct 24, 2025 4:01 PM ET
508-KCurrent report: other events0001628280-25-045513Oct 20, 2025 4:04 PM ET
...

Context Therapeutics SEC Filings API

Pull Context Therapeutics's SEC filing index, with links to every filing and exhibit, into your own tools with the Business Quant SEC Filings API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/secfilings?ticker=CNTX&formtype=10-K,10-Q&api_key=YOUR_API_KEY

Context Therapeutics SEC filings: questions

What is Context Therapeutics's CIK number?

Context Therapeutics's Central Index Key (CIK) is 1842952, written 0001842952 in EDGAR's ten-digit form. The SEC files every Context Therapeutics filing under this number.

When did Context Therapeutics file its latest 10-K and 10-Q?

Its latest annual report, the 10-K for the fiscal year ended Dec 31, 2025, was filed on Mar 23, 2026; its latest quarterly report, the 10-Q for the quarter ended Sep 30, 2026, was filed on Nov 10, 2026.

How often does Context Therapeutics file with the SEC?

Context Therapeutics made 43 SEC filings in the last 12 months, most often 12 8-K filings, 12 SCHEDULE 13G filings and 10 Form 4 filings. The most recent, a current report (8-K), was filed on Nov 10, 2026.

Is there an API for Context Therapeutics's SEC filings?

Yes. The Business Quant SEC Filings API returns Context Therapeutics's filing index (309 filings), with links to every filing and exhibit on EDGAR: /secfilings?ticker=CNTX. Free API keys are available. SEC Filings API docs